IQQS:XETRA:XETRA- (EUR)

ETF | Others |

Last Closing

USD 44.415

Change

+0.79 (+1.80)%

Market Cap

N/A

Volume

6.18K

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-03-14 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
JARI:XETRA

+0.38 (+0.84%)

USD 96.80B
EUNL:XETRA

+1.12 (+1.16%)

USD 84.07B
FRCJ:XETRA

+0.31 (+1.33%)

USD 79.79B
AW15:XETRA

+0.12 (+0.89%)

USD 58.88B
FJPR:XETRA

+0.05 (+0.96%)

USD 44.90B
EXX7:XETRA

+0.31 (+1.35%)

USD 28.25B
SPYL:XETRA

+0.15 (+1.16%)

USD 23.43B
PPFB:XETRA

+0.03 (+0.06%)

USD 19.49B
XDEE:XETRA

+0.11 (+1.07%)

USD 12.83B
EUN5:XETRA

+0.12 (+0.10%)

USD 12.26B

ETFs Containing IQQS:XETRA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 7.32% 84% B 77% C+
Dividend Return -10.29% 42% F 14% F
Total Return -2.97% 37% F 36% F
Trailing 12 Months  
Capital Gain 1.80% 32% F 36% F
Dividend Return -9.76% 49% F 5% F
Total Return -7.96% 10% F 15% F
Trailing 5 Years  
Capital Gain 60.46% 48% F 51% F
Dividend Return -7.96% 52% F 4% F
Total Return 52.50% 44% F 45% F
Average Annual (5 Year Horizon)  
Capital Gain 6.51% 49% F 50% F
Dividend Return 7.44% 51% F 51% F
Total Return 0.93% 66% D+ 46% F
Risk Return Profile  
Volatility (Standard Deviation) 17.61% 25% F 38% F
Risk Adjusted Return 42.25% 38% F 44% F
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.